Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT04974073 | Development of PHY606 as Adjunct Therapy for Anemia Patients | PHASE3 | COMPLETED | 39 | — | — | Aug 22, 2017 | Nov 18, 2019 | Aug 16, 2021 | 1 | Taiwan |
Collect blood and measure the level of serum cytokines.
| Arm | Type | Description |
|---|---|---|
| control group | NO_INTERVENTION | with traditional western medicine treatment based on underlined disease |
| PHY606 | EXPERIMENTAL | PHY606 7.5gm BID for 3 months |
| Healthy group | OTHER | PHY606 7.5gm BID for 2 days |
| Name | Type | Description |
|---|---|---|
| PHY606 | DRUG | Danggui Buxue Tang is a well-known TCM formula indicated for anemia through immune modulation and increase energy metabolism |
Inclusion Criteria: * female: Hb\<11 g/dL; male: Hb\<13.5 g/dL * has no allergic reaction to TCM Exclusion Criteria: * below 20 years old * ever drug abuse or still in drug abuse * pregnant or in breast-feeding women * with psychotic disorders * cardiac arrhythmia with pacemaker * dyscoagulation ...